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A B S T R A C T   
Background: Healthcare services such as diabetes risk-assessment are increasingly common in community 
pharmacies. Knowledge of community pharmacists’ experiences of such services could ease the implementation 
of a larger-scale service. 
Objectives: To explore Norwegian pharmacists’ experience of a diabetes risk-assessment service, including 
analytical quality control, in a community-pharmacy setting. 
Methods: Three focus-group interviews were conducted in Norway between August and September 2017. Sys-
tematic text condensation was used, an analytic approach well suited for thematic content analysis across 
interview data. Fourteen pharmacists took part, recruited from a project offering a diabetes risk-assessment 
service, including measurements of Glycated hemoglobin A1c (HbA1c), in Norwegian community pharmacies. 
Results: The pharmacists emphasized the importance of using their knowledge and skills to promote good health. 
They considered offering this service as being compatible with their role as pharmacists. As communication is an 
essential part of their work, the pharmacists evaluated their communication skills as being good. Nevertheless, 
how to communicate the offering of this service was seen as a challenge, for instance recruiting participants and 
communicating in an understandable and professional way. Inclusion of the whole pharmacy staff as a team was 
experienced as an important success factor for implementation of a risk-assessment service. Analytical quality 
control was perceived as being a natural part of their job and a manageable task. 
Conclusions: Offering a diabetes risk-assessment service is in line with the way a selected group of Norwegian 
community pharmacists perceived their professional role. However, they were uncomfortable recruiting par-
ticipants, and expressed the wish for more support from the pharmacy chain. Our results add performance of 
analytical quality control as part of the ongoing development involving expansion of pharmacists’ professional 
role. Future implementation studies may also benefit from giving both the pharmacy staff and customers suffi-
cient time to familiarize themselves with the new service before measuring effects.   
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Introduction 
Worldwide, non-communicable diseases caused 73% of the total 
deaths in 2017 – a 40% increase on the figure for 1990.1 This global 
burden of non-communicable diseases can be reduced by using available 
healthcare professionals for early detection of those at high risk of dia-
betes or heart disease. Community pharmacists are described as 
underutilized health professionals, because of their advanced skills in 
pharmacotherapy and their easy accessibility within the community.2 A 
joint guideline from the International Pharmaceutical Federation (FIP) 
and the World Health Organization (WHO) thus suggests that pharma-
cists should be more involved in disease prevention by offering services 
such as point-of-care testing (POCT) and screening activities for patients 
at higher risk of disease.3 
Norway, with a population of 5.3 million, has almost 1000 phar-
macies, and the community-pharmacy market is dominated by 3 inter-
national chains.4 About 94% of the population have a pharmacy in their 
municipality, and Norwegian pharmacies have in total more than 170, 
000 customers daily.4 The Norwegian government recommends that 
healthcare professionals be used more effectively, and that pharmacies 
carry out new tasks.5 The Norwegian Pharmacy Association supports 
this development and recommends that Norwegian community phar-
macies offer a variety of health services.6 Pharmacists are positive to 
their role as health professionals,7 and a Norwegian study found that 
pharmacists wanted more responsibilities, offering person-centered 
services.8 In accordance with the Norwegian Pharmacy Association 
recommendation,6 new health services have increasingly been offered in 
Norwegian pharmacies over the past decade. In Norway there are 2 state 
reimbursed services which are free of charge for the patient: the struc-
tured pharmacist-led inhalation-technique assessment, implemented in 
2017,9 and the New Medicine Service (Medisinstart), implemented in 
2018.10 Other community pharmacy services, such as a mole screening 
service, blood pressure measurements, smoking cessation, and vacci-
nation, are offered more sporadically, and most often require a customer 
payment. These pharmacy services contribute to the extending profes-
sional role of the pharmacist in public health in Norway. 
Given the growing prevalence of type 2 diabetes, identifying persons 
at risk of this disease may be another public health service where the 
pharmacies could be used. The Norwegian Directorate of Health does 
not recommend an active screening for T2D in the population, but rec-
ommends that general practitioners (GPs) assess the risk of T2D in 
people who have close relatives with diabetes, people with high body 
mass index (BMI) and/or who are physically inactive, and in people 
from Asia or Africa (a non-western background).11 The patients pay a 
co-payment of 20–25 EUR for a GP-consultation. As of today, Norwegian 
pharmacies do not offer diabetes risk assessment service on a regular 
basis. In 2016 we therefore first performed a feasibility study,12 inves-
tigating a diabetes risk assessment service in Norwegian community 
pharmacies. Based on results from the feasibility study,12 we performed 
a larger study to explore if Norwegian community pharmacies could 
identify individuals with a high risk of developing T2D by offering a 
diabetes risk assessment service including a measurement of hemoglo-
bin A1c (HbA1c)(Manuscript under revision). Box 1 describes the 
methods of the study. Unfortunately, the participating pharmacies only 
managed to recruit one tenth of the target number of 
pharmacy-customers estimated based on the recruitment rate of the 
feasibility study.12 The reasons for this were unclear. 
While several studies, including reviews, have found that pharma-
cists’ perceptions are shifting towards delivering patient care,17,18 few 
studies have explored pharmacists’ experiences regarding a diabetes 
Box 1 
An overview of the methods in the community pharmacy diabetes risk assessment study (Manuscript under revision). 
Participating pharmacies: 
The regional manager from 1 of the 3 major pharmacy chains in Norway sent an e-mail to all their 350 pharmacies. Twenty agreed to participate. 
Of these, 11 pharmacies were allocated to the group who offered a HbA1c measurement to customers with a high risk of developing T2D. The 
pharmacies varied in size (number of customer prescriptions per day varied from 41 to 270), were from all across Norway, and both rural and 
urban areas were represented. 
Staff training: 
From each pharmacy, 2 pharmacists participated in a training program and were then responsible for providing the service. The participating 
pharmacists received written procedures for recruitment, diabetes risk assessment and how to counsel the participants with different risk 
profiles. They attended web-based courses covering internal and external analytical quality control of the HbA1c instrument. In addition, they 
attended a one-day course day where they were trained, through role playing, in how to convey risk information. They were also given practical 
training in the use of the HbA1c POC instrument and performing quality control procedures (More details on the quality control program is 
published13). 
The risk assessment service: 
Over 6 months the 11 Norwegian community pharmacies offered a diabetes risk-assessment service and pharmacy customers 45 years or older 
who wished to participate contacted the pharmacy staff. This free service consisted of a diabetes risk-assessment tool which included questions 
about risk factors for developing T2D such as age, BMI and family with diabetes.14,15 Participants with a high risk of developing T2D were 
offered a HbA1c measurement. All participants received lifestyle recommendations from the Norwegian national guideline for diabetes.11 After 
2 months all participants were followed up with a questionnaire or a phone call. Marketing of the service included leaflets in the participating 
pharmacies and in nearby pharmacies, as well as posters both inside and outside the pharmacies.12 In addition, there was some publicity in the 
radio and regional newspapers, on the pharmacy chain website and Facebook. 
Quality assurance of HbA1c: 
The pharmacies were enrolled in an external quality assessment (EQA) scheme and performed internal quality control (IQC) regularly.12,13 
Participation in the EQA scheme is an objective means of evaluating the reliability of the HbA1c results. The pharmacies analyzed control 
material distributed by an independent external coordinator.16 The test results obtained were compared with a target value obtained by a 
Reference Laboratory, and the performance were evaluated based on predefined limits. The results were evaluated for trueness and precision. 
IQC implied that the pharmacy analyzed samples from the producer of the HbA1c instrument in 2 levels on all days that a customer HbA1c 
measurement was performed, and upon opening a new box of reagent. Thus, IQC is a continuously method validation by monitoring the ac-
curacy of analytical data obtained in the pharmacy.  
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risk-assessment service in a community-pharmacy setting.19–21 Those 
that have done so have found factors such as lack of time and shortage of 
staff to be the main barriers to providing such a service.19,20 These 
studies were performed in Australia, Thailand and the United Kingdom 
(UK),19,20 and there have been no such studies in the Scandinavian 
countries. Differences in healthcare systems and pharmacy practice may 
affect attitudes and implementation of healthcare delivery in a phar-
macy setting. It is thus important to explore the factors that may influ-
ence pharmacists’ experiences regarding diabetes risk-assessment 
intervention in each country. Furthermore, experiences of analytical 
quality control among community pharmacists have to our knowledge 
not been explored. Increased understanding of community pharmacists’ 
experiences with such a service, including the analytical quality 
control-component, could ease implementation of a generalized service. 
The aim of this study was thus to explore experiences pharmacists who 
had participated in delivering a diabetes risk-assessment service in a 
community-pharmacy setting. 
Methods 
Design of the study 
A qualitative study with 3 focus-group interviews was conducted.22 
The consolidated criteria for reporting qualitative research (COREQ) 
were used.23 
Recruitment and participants 
All the 22 project pharmacists, 2 from each pharmacy, who partici-
pated in a diabetes risk-assessment-service trial in Norwegian commu-
nity pharmacies (Box 1) (Manuscript under revision, 12) were invited by 
email to participate in a focus-group study. Ten of the 11 pharmacies 
were represented in the focus-group interviews. Four of the pharmacies 
sent both of their project pharmacists, while 6 pharmacies only sent one. 
Reasons given for non-attendance were that no suitable stand-in phar-
macist was found at the time of the group interview, or that the project 
pharmacists no longer worked in the pharmacy. The diversity of gender, 
age, work experience and place of education is shown in Table 1. 
Preparing for the interviews 
Three of the authors (ARJ, UØS and RLSK) developed a semi- 
structured interview guide with main topics and open-ended ques-
tions. KS and MR read the guide in advance of the interviews and gave 
feedback before the final version was settled (Supplementary file 1). The 
3 main topics were 1) the pharmacist’ experience of implementation of 
the diabetes risk-assessment service in their pharmacy; 2) the pharma-
cists’ understanding of their role in this project, and 3) their experience 
of and attitudes to blood-sample analysis in the pharmacies. The ma-
jority of the questions were the same in each interview, while the follow- 
up questions varied, as the focus group moderator followed the flow of 
the group discussion. The interview guide was reviewed after reading 
the transcripts from the first 2 focus-group interviews. Because there was 
a discussion in the first 2 interviews as to whether or not communication 
skills could be learned, the authors included this a topic in the interview 
guide for the third focus group. 
Data collection 
UØS moderated the first group focus group alone, and the second 
with KS as a co-moderator. The final focus group was moderated by AJR 
with UØS as co-moderator. All the focus-groups were held in small hotel 
conference rooms that were easily accessible for the project pharmacists. 
The first 2 focus groups each had 4 participants, the first representing 3 
different pharmacies, the second 4 different pharmacies. The final 
interview had 6 participants, representing 3 different pharmacies. Each 
lasted about 90 min. At the end of the first focus-group the moderator 
gave a short summary, giving the participants the opportunity to clarify 
any possible misunderstandings or add points that had been missed. In 
the final 2 groups the co-moderator had this role. The co-moderators in 
focus group 2 and 3 also asked some clarifying questions and took field 
notes. All interviews were audio-recorded and were transcribed 
verbatim by AJR using HyperTRANSCRIBE™ for Mac 2013 (V.1.6.1; 
ResearchWare Inc, Randolph, Massachusetts, USA). Data collection took 
place between August and September 2017. 
The research team 
First author is a pharmacist and a Doctor of Philosophy (PhD) 
candidate and has experience working in community pharmacies. Last 
author is a graduate engineer, an associate professor in laboratory sci-
ence and the main supervisor for the PhD candidate. Second and third 
authors are pharmacists; both hold a PhD in social pharmacy and work 
as associate professors. Three of the authors have experience of quali-
tative research. The second last author is a physiotherapist, holds a PhD 
and works as a professor. She is highly experienced in qualitative 
research. She had no contact with the participants. All the researchers 
are female. 
Analysis 
Systematic text condensation (STC) was used for data analysis.24 STC 
is an analytic approach well suited for thematic content analysis across 
interview data. The method includes 4 steps in the qualitative analysis 
process, quite similar to other existing thematic content analysis. First, 3 
of the authors read the transcripts separately, to obtain an overview of 
the data, and identified preliminary themes that represented the various 
aspects of the pharmacists’ experiences of the diabetes risk-assessment 
study (overview of the themes and the analytical process, Fig. 1). The 
authors then met for discussion and reached a consensus on the pre-
liminary themes to take further in the analysis. Secondly, units of 
meaning, a text fragment containing information relevant to the 
research question, were identified, and coded independently. Thirdly, 3 
of the authors discussed the coding, and a process was followed to reach 
a consensus. A condensate was then developed for each code group in 
first-person form, aiming to catch the most important meanings in the 
meaning units, adhering closely to the pharmacists’ wording. It contains 
a transformation from the pure listing of the meaning units and is hence 
an interpretation grounded in the meaning units. Finally, in the fourth 
step, generalized descriptions of the pharmacist’s experiences with the 
diabetes risk assessment was developed (analytical text) and illustrated 
Table 1 
General characteristics of the pharmacists participating in the 3 focus-group 
interviews (N=14).  
Age (years), median (min–max) 40 (27–64) 
Gender, n 
Women/Men 8/6 
Level of education, n 
Bachelor of pharmacy 5 
Master of pharmacy 9 
Graduating year, median (min–max) 2007 (1981–2017) 
Pharmacy school, na 
Norwayb 11 
Outside Norwayc 4 
Pharmacy work experience (years), median (min–max) 10 (3–36) 
Current position, n 
Pharmacist 9 
Pharmacy manager 5  
a The total is 15, because one pharmacist was educated both in Norway and 
abroad. 
b The pharmacy schools represented were the University of Oslo, Oslo 
Metropolitan University and the Arctic University of Norway. 
c Denmark, Serbia and Iceland were represented. 
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by a quotation. At each step 4 of the authors deliberated over the code 
groups/text. MR also read the code groups and the analytical text and 
gave feedback throughout the analytical process. After the results sec-
tion had been written, the transcripts were read one final time to make 
sure that nothing important that reflected the aim of this study had been 
lost during the analytical process. Supplementary file 2 shows an excerpt 
of the analysis from step 2 to step 4. 
Ethics 
The study was approved by the Norwegian Social Science Data Ser-
vice (Project number: 53920). The Norwegian Regional Ethics Com-
mittee was contacted, and it stated that ethical approval was not 
required (document ID: 717671). Participation was voluntary, and all 
the participants signed an informed consent. Before the focus-group 
interview started, the pharmacists were reminded that the information 
shared was confidential. The participants could withdraw from the study 
at any time before the group interviews were held, without giving any 
reason. The names of the participants were not included in the tran-
scripts, and the transcripts were password-protected and stored at a 
secure location. 
Results 
The analysis identified 4 main result categories (Fig. 1), namely: We 
want to use and show our professional skills; Recruitment was disap-
pointingly challenging; Communication with customers can be both a 
challenge and an opportunity, and Analytical quality control is 
manageable and matches our role. They are elaborated on below. 
We want to use and show our professional skills 
In general, the pharmacists wished to use their knowledge in order to 
improve customers’ health. This contrasted with how they perceived the 
development of Norwegian pharmacists’ role in recent years. The 
pharmacists emphasized that they would prefer more attention to health 
promotion and less focus on sales. 
“It was nice to do something professional. Because in pharmacies 
there is a lot of focus on sale, and it is a good idea to have a pro-
fessional project. Because that’s where we want to be. To show what 
we are able to do.” (FG3/1) 
Assessing the risk of developing T2D was an opportunity to steer the 
development of the pharmacists’ role towards more health promotion. 
The pharmacists appreciated the research element of the project and 
believed it was important to explore whether the service fulfilled its 
purpose before implementation in the pharmacies. Non-research-based 
services had been offered as a project in some of the pharmacies, and 
the concern was raised that this could undermine people’s long- 
established trust in pharmacies. 
“I also think it is extremely important to get some documentation 
about what works and what doesn’t work in the pharmacies. (…). Of 
course, everything we do in the pharmacy is important and means a 
lot to the customer. But we can’t document it. We just say it works. 
So, we have to get some documentation.” (FG1/2) 
The pharmacists found it motivating to participate in the project and 
be involved in diabetes risk-testing. Although they found it exciting 
offering health services at the pharmacy, they were also concerned that 
the service could create a conflict of interest with GPs. Diagnostics is an 
important part of GPs’ field of knowledge, and the pharmacists 
emphasized that they did not want to intrude into this domain. 
“The physicians feel that we interfere and take a share of the market 
they make their money from … So, we’re a bit careful because we do 
not want to get into a dispute with the GPs.” (FG2/1) 
The pharmacists had, however, identified that their customers 
needed easier access to health information and risk assessments than 
GPs’ offices could provide. They believed they could fill this gap without 
taking on part of the GP’s role. A few pharmacists mentioned the criti-
cism that risk-assessment services may contribute to increased health 
anxiety. Most pharmacists, however, believed they could provide reas-
surance for people at a low risk of developing diabetes. 
Fig. 1. The analytic process using Systematic Text Condensation.24  
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“What we did, it was probably more sorting out those who did not 
have diabetes, more than detection of disease. In most cases.” (FG3/ 
2) 
Recruitment was disappointingly challenging 
In general, the pharmacists found it hard to recruit participants to the 
risk-assessment service and identified this as a main barrier to imple-
mentation of the service. Some of the participants stated that pharma-
cists are not ‘born sellers’ and were uncomfortable embracing this role, 
because it entailed being proactive and outreaching. The pharmacists 
did, however, recognize their changing role in terms of focusing more on 
sales. 
“It was difficult. I think it was difficult to ask people if they wanted to 
be tested for diabetes, because I was so afraid that people would be 
upset. ‘Do I look like I have diabetes?‘" (FG2/3) 
The recruitment training that the study pharmacists received before 
the project started was helpful, but despite this they found it difficult. 
Their initial optimism decreased as the project proceeded, because they 
did not manage to recruit the expected number of study participants. 
Words such as ‘sadness’ and ‘embarrassment’ were used to describe 
emotions related to what they perceived as a failure to achieve the 
recruitment goals. While some of the pharmacists mentioned that their 
working days were too busy to allow time for recruitment, others did not 
see time as a challenge. 
The pharmacists discussed the fact that pharmacy customers need 
time to grow accustomed to new pharmacy services, and that customers 
will not ask for an unfamiliar service at the pharmacy. The pharmacists 
suggested that if this service had been permanent, pharmacy customers 
might have requested it more frequently. They commented that an 
increased number of customers requested the service after the 6-month 
inclusion period. 
“We did not have the impression that there was a huge demand for it 
[this service] either. Perhaps it was a bit too new for the customers. 
They are not used to this type of service at the pharmacy.” (FG3/2) 
The pharmacists suggested that better marketing of the project 
would have created more awareness and recruited more participants. 
Some pharmacists mentioned that the posters could have been larger 
and the flyers more informative. They also commented that while other 
national campaigns offering new health services in pharmacies have 
been promoted through TV commercials and large-scale media 
coverage, that was not the case for this project. Increased local cam-
paigning within the pharmacy was stated as being challenging, espe-
cially at times when the pharmacy was short of staff. A continuous focus 
on the project on the part of all the staff was important in terms of 
motivating the staff and recruiting participants. One pharmacist, for 
example, shared the story of how identifying T2D in one of their par-
ticipants made the entire pharmacy workforce feel that the service was 
important and meaningful, and gave them extra motivation. 
“We worked together as a team, and everyone had to get involved, 
otherwise we could not reach our goal. And we struggled a bit 
because we did not have enough people at work.” (FG2/2) 
Most of the pharmacists did not see money as being a main moti-
vating factor, though one pharmacist suggested that a personal payment 
for each risk assessment they performed would have been motivating, 
making a comparison with GPs’ remuneration for consultations. 
Communication with customers was both a challenge and an opportunity 
Communication was a crucial part of the risk-assessment service. The 
pharmacists had received differing amounts of communication training 
during their pharmacy education, and there was some discussion about 
whether communication skills were something that could be learned, or 
whether they were simply part of one’s personality. Comprehensible and 
professional communication with the participants during the risk- 
assessment service was sometimes perceived as being challenging, 
especially when they were not fluent in Norwegian. It was emphasized, 
however, that communicating with customers is something pharmacists 
are generally comfortable with, because talking to customers is a major 
part of their job. At first some of the pharmacists were nervous about this 
task. However, as they experienced that they had enough knowledge 
about diabetes to answer the customers’ questions, the communication 
became easier to handle. 
“I think it was okay to communicate with them [low-risk customers]. 
We do have knowledge about diabetes and what may increase or 
reduce the risk, and we are used to talk with customers. We speak 
their language and it’s not too advanced.” (FG3/6) 
During the project, the pharmacists experienced the importance of 
explaining to the participants in advance that the HbA1c measurement 
would only be performed on those with a high-risk score. Otherwise 
some of the participants would get annoyed, because the HbA1c mea-
surement was their main reason for participating. Many participants 
were nevertheless pleased when the pharmacists managed to commu-
nicate that having a low-risk score was something positive. Despite the 
fact that many pharmacists found risk communication manageable, 
some found it challenging to communicate the seriousness of the dia-
betes risk without frightening the participant. 
“ … beforehand I was quite nervous. When I took those blood sam-
ples, I hoped it was not a high [HbA1c] score. I found it hard to tell 
them that … to make them understand that they had to visit their 
doctor without frightening them. What if they went home and were 
really afraid? But they had to understand that it was serious.” (FG2/ 
3) 
One pharmacist was apprehensive about addressing high weight and 
waist measurements without offending the participants. Others saw this 
service as a great opportunity to talk to the participants about the as-
sociation between abdominal fat and increased risk of heart disease and 
diabetes. Many participants also addressed their weight themselves, 
giving the pharmacists an opportunity to inform them about weight and 
lifestyle changes, focusing on the fact that even small measures can have 
a positive effect on lowering the risk of developing T2D. 
The pharmacist-patient encounters in this service were described to 
differ significantly from those that occur during routine dispensing in 
the pharmacies and they gave other opportunities. The pharmacists re-
ported that the participants appreciated the fact that the pharmacists 
had time to talk to them, as well as having a conversation in a more 
private room rather than over the counter. One pharmacist reported how 
an older couple were so pleased with the service that they insisted on 
giving them a hug. Most pharmacists experienced the service as being 
positive, not only for the participants but also for themselves. The en-
counters with the participants expanded the pharmacists’ horizons in 
several ways; it was more than just a risk assessment. 
“(…) what was interesting to me was the amazing patient consulta-
tions, not only about diabetes, but also other things. So, you got a lot 
of contact with people, patients, customers, which enriched my soul 
(…)." (FG1/1) 
Analytical quality control is manageable and matches our role 
Implementation of the analytical quality assurance was considered 
straightforward. Many pharmacists mentioned earlier experiences as 
being useful for the analytical quality assurance, e.g. measurements of 
blood glucose and risk assessment for heart disease at the pharmacy, 
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laboratory work during their studies or previous work in the medical 
industry. Despite this, one pharmacist was a little worried about the 
blood sampling. After her first sampling, however, she felt relieved, and 
found that it was nothing to worry about. 
The pharmacists were aware of the consequences if they deviated 
from the quality-assessment procedures. Deviations could affect the 
quality of the HbA1c measurement and have severe consequences for 
the participants. The performance of internal and external quality con-
trol of the HbA1c instrument allowed them to rely on the HbA1c 
measurements. 
“It’s quite reassuring, I think. That you actually perform a control. 
So, when you tell the customer the result, you know it is correct.” 
(FG3/4) 
A few pharmacists did, however, question the benefit of the analyt-
ical quality-assurance procedures. One pharmacist admitted that as a 
consequence of the slow recruitment, the focus on recruitment was 
increased at the expense of spending enough time on analytical quality 
assurance. 
The pharmacists experienced differing challenges in the performance 
of the internal and external analytical quality control. These included 
performing the internal quality control analysis regularly as part of their 
daily routine and having a functional system for recording the results. 
Furthermore, they found that it was technically more difficult to analyze 
the internal and external control compared to blood samples, and the 
procedures were time consuming. As they were not used to analyzing 
external quality controls, and since they received the controls material 
only every third month, they did not really get into the routine of the 
procedure during the project period. Sometimes they also forgot to keep 
the material refrigerated. However, they believed that these challenges 
were associated with start-up difficulties that would decrease when the 
diabetes risk service eventually became routine. 
Discussion 
Main findings 
The aim of this study was to explore Norwegian pharmacists’ expe-
riences in offering a diabetes risk-assessment service, including analyt-
ical quality control, in community pharmacies. The pharmacists 
emphasized the importance of using their knowledge and skills to pro-
mote good health in the population. They also perceived that offering 
this service was compatible with their professional role. However, 
recruiting participants was deemed challenging. As communication is an 
essential part of their work, many pharmacists evaluated their 
communication skills as being good, though some aspects of commu-
nication when offering this service were seen as a challenge. To our 
knowledge, this is the first study exploring community pharmacists’ 
experiences of participating in a quality control scheme to ensure the 
accuracy and precision of their laboratory testing. The analytical quality 
control was seen as a natural part of their job and a manageable task. 
Strengths and limitations 
A strength of this study is the fact that the members of the research 
team have different backgrounds and experience of qualitative research, 
and that they analyzed the data together using a predefined iterative 
method.24 Also, KS and MR were experienced in using focus groups, and 
both of them contributed to the planning and analyzing of the study. The 
use of Systematic Text Condensation as an analytic approach allows less 
experienced qualitative researchers to maintain a responsible level of 
methodological quality.24 The group dynamic provided a rich and var-
ied basis for 2 of the 3 focus groups – one of the strengths of using 
focus-group interviews.22 In the third group the conversation was not as 
fluent, still this group contributed with valuable input to the research 
question. All together these 3 focus groups gave a sufficient data to 
answer to the research question. Ten out of the 11 pharmacies from the 
main study were represented in the focus groups. The 3 dominating 
pharmacy chains in Norway are very similar. Still, if the service had 
been introduced in all pharmacies in Norway, rather than in self-selected 
pharmacies, there may have been a broader range of experiences, and 
other themes may have emerged. The fact that AJR, who had been 
closely involved in developing the risk assessment service, did not attend 
2 of the focus groups may have made it easier for the participants to talk 
about negative experiences regarding the diabetes risk-assessment ser-
vice. They did not need to worry about disappointing her. This may 
explain why the diabetes risk-assessment study was criticized more 
during the initial interviews, in which AJR did not attend, than in the 
final interview, for which she was the moderator. Inclusion of a pur-
posive sample of pharmacists is also a strength and gives the study 
greater informative power.26 
In line with their role as pharmacists 
The pharmacists participated in this diabetes risk-assessment study 
because they wanted to expand their role in terms of offering health 
services. This is line with an English study, in which the community 
pharmacists considered diabetes prevention to be part of their public- 
health role.20 It is also in accordance with the FIP’s and the WHO’s 
recommendation regarding increased involvement of pharmacies in 
disease prevention.3 Thus, our study seems to have narrowed the gap 
described in an earlier study by Svensberg et al.,8 between the way 
community pharmacists perceived their current practice and the way 
they wanted to practice. In that study, the pharmacists described their 
ideal way of practice as a more patient centered care. However, they felt 
powerless in terms of their possibility of steering their role more towards 
patient care.8 In our study, however, the pharmacists seemed to take 
responsibility for their role development, by choosing to participate in 
the project. This may be because “our” pharmacists represent a sample 
who are especially willing to take responsibility for development of their 
role. Also, through participation in this diabetes risk assessment service 
the pharmacists experienced that an expansion of their role towards 
extended patient care was feasible. The pharmacists in the earlier Nor-
wegian study8 represent the status quo of pharmacy practice in Norway 
at the time of the study. In the UK community pharmacies provide the 
NHS Health Check program which assess an individual’s risk of devel-
oping diabetes.27 Thus, the UK pharmacists’ experiences20 probably also 
reflect that the service is more integrated in the pharmacy. 
Recruitment of participants as a main barrier 
The pharmacists in this study identified several reasons why they did 
not succeed in recruiting the number of customers they had hoped for. 
They did not feel that the recruitment-aspect of the service was a natural 
part of their role. In line with this, a systematic review exploring phar-
macy staff’s perspectives regarding the barriers to and facilitators for 
implementing new services at a national level, found difficulty recruit-
ing patients to be a barrier.28 Based on our findings, we recommend 
including specific practical skills training focused of how to approach 
customers about new services when performing studies such as this. The 
systematic review also explored pharmacists’ perspectives with regard 
to implementation of innovations, and reported a need for better 
advertising and promotion.28 Social support is a known factor for suc-
cessful implementation,28 and this aligns with the finding that the 
pharmacists stated that the recruitment process was more successful 
when all the pharmacy staff worked together as a team and took a 
proactive role in recruitment. This adds to the research showing how 
important good pharmacy teamwork is for innovation, effective services 
and improved patient care.29 
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The service opened for more meaningful communication 
The pharmacist/participant communication in the diabetes risk- 
assessment project was described as more meaningful than the phar-
macist/customer communication in the pharmacists’ routine work. 
Likewise, an American study found that customers appreciated the un-
divided attention they received in a similar setting compared with a 
standard conversation in the pharmacy.30 Use of a private room may 
have an effect on what a customer decides to disclose and was probably 
an important success factor. For example, the patients opened up and 
initiated discussions about lifestyle issues. Improved involvement of 
pharmacists and a better relationship with the patients28 have also been 
found in a systematic review of services such as a medicine use review.31 
The risk-assessment service in this study did not involve use of computer 
screens, and this may also have had a positive effect on pharma-
cist/participant communication. A Swedish study found that computer 
screens can limit pharmacists’ ability to practice patient-centered 
care.32 It seems as if communication in such a context provides a new 
dimension of pharmacist/customer interaction, compared with standard 
communication over the counter. 
Risk communication is a complex process,33 and a barrier identified 
in our study was finding a balance in terms of risk communication. This 
is in line with Australian and English studies, which explored commu-
nity pharmacists’ experience regarding risk communication in connec-
tion with alertness-impairing medicines34 and Human 
Immunodeficiency Virus (HIV) testing.35 They found that some of the 
barriers having an adverse effect on risk communication were discom-
fort in communicating the result to the patient, and whether the 
customer had a different agenda than that of the pharmacists.34,35 
The amount and nature of communication training that was included 
in their basic pharmacy education varied from one participating phar-
macist to another in this study. We experienced that the pharmacists 
appreciated the extra communication-practice that was included in the 
training prior to the study. This gave them increased confidence when 
communicating risks. Still, in hindsight there should have been more 
recruitment-specific practice, to give them tools to approach different 
types of customers. 
Analytical quality control in community pharmacies 
The pharmacists in this study were familiar with laboratory work and 
identified analytical quality control as something that matched their 
professional role. Previous studies have also shown that many phar-
macists are willing to provide POCT, e.g. for influenza, streptococcal 
pharyngitis36 and human immunodeficiency virus (HIV),35 in a 
community-pharmacy setting. Other studies exploring pharmacists’ ex-
periences of internal and external analytical quality control for POCT 
have not been found. A systematic literature review did find that 
analytical POCT in pharmacies is acceptable compared with the labo-
ratory standard,37 but did not explore whether pharmacists identified 
analytical quality control as being part of their role. This aspect was, 
however, explored in this study, and the approach was in line with the 
finding that pharmacists wanted to expand their professional role. 
Practical implications and further research 
The results indicate that pharmacists need more support and training 
in promoting a diabetes risk-assessment service, because they did not 
feel comfortable actively promoting the service themselves and identi-
fied this as a main barrier to implementation of the service. Role-playing 
sessions, where the pharmacists could practice different approaches to 
recruitment would be useful. In addition, both the pharmacy manage-
ment and the pharmacy-chain management could assist in the promo-
tion, as well as the pharmacy association. Future research into this 
aspect is needed – e.g. pharmacists’ perception of offering such a service 
with a greater focus on marketing outside the pharmacy, including TV 
and social-media advertising. The results also emphasized the impor-
tance of all the pharmacy staff working together as a team. It is thus 
suggested that future research should focus on any difference in 
recruitment when the entire pharmacy staff are involved, compared 
with only having a few dedicated project pharmacists. Future imple-
mentation studies may also benefit from giving both the pharmacy staff 
and pharmacy customers sufficient time to familiarize themselves with 
the new service before measuring uptake and effects. In a full-scale 
implementation of such a service, lack of reimbursement for the risk 
assessment service could be a major barrier to implementation and the 
effect of customers co-payment should also be explored. Also, as the 
results of this study add the performance of analytical quality control as 
part of the ongoing development of expanding pharmacists’ professional 
role, a confirmation of this finding would be valuable. 
Conclusion 
Offering a diabetes risk-assessment service is in line with how a 
selected group of Norwegian community pharmacists perceived their 
professional role. However, they were uncomfortable recruiting partic-
ipants, and expressed a wish for more support from the pharmacy chain 
here. Inclusion of the entire pharmacy staff as a team was deemed an 
important success factor for implementation of such a service and should 
be considered before implementing a diabetes risk service on a larger 
scale. Also, the results add the performance of analytical quality control 
as part of the ongoing development of expanding pharmacists’ profes-
sional role. 
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